14 November 2023 PYC’S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE 0 minute read Pharma/Biotech By Cate Swannell Previous Post Next Post